Enabling better health outcomes from infectious diseases through rapid diagnostics
Rapid Infection Diagnostics (RID) Inc. was founded in August of 2019 with a mission of reducing death and disability from infectious diseases via state-of-the-art diagnostic technology.
RID Inc. leverages advanced mass spectrometry to enable a suite of rapid diagnostic tests that reduce microbiology testing times from days to hours.
Mission
Save lives through RAPID microbial analysis
Key Value Proposition
RID technology enables the fastest and most comprehensive microbiology testing workflow
for large microbiology laboratories
Team&Partners
Meet the team and partners behind RID
RID Technology
Our team has developed Hopper™, a rapid, high throughput metabolomics-based platform for identification (ID) and antibiotic susceptibility testing (AST) of microbes on a single platform. You can also view our existing patents here.
“The impact of RID Inc. technologies will be measured in thousands of lives and millions of dollars saved annually”
Dr. Ian Lewis, CEO